Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

Bibliographic Details
Main Authors: Betancor, Gilberto, Garriga, César, Puertas, Maria C, Nevot, María, Anta, Lourdes, Blanco, José L, Pérez-Elías, M Jesús, de Mendoza, Carmen, Martínez, Miguel A, Martinez-Picado, Javier, Menéndez-Arias, Luis
Format: Online
Language:English
Published: BioMed Central 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468358/
id pubmed-3468358
recordtype oai_dc
spelling pubmed-34683582012-10-11 Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy Betancor, Gilberto Garriga, César Puertas, Maria C Nevot, María Anta, Lourdes Blanco, José L Pérez-Elías, M Jesús de Mendoza, Carmen Martínez, Miguel A Martinez-Picado, Javier Menéndez-Arias, Luis Research BioMed Central 2012-08-13 /pmc/articles/PMC3468358/ /pubmed/22889300 http://dx.doi.org/10.1186/1742-4690-9-68 Text en Copyright ©2012 Betancor et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Betancor, Gilberto
Garriga, César
Puertas, Maria C
Nevot, María
Anta, Lourdes
Blanco, José L
Pérez-Elías, M Jesús
de Mendoza, Carmen
Martínez, Miguel A
Martinez-Picado, Javier
Menéndez-Arias, Luis
spellingShingle Betancor, Gilberto
Garriga, César
Puertas, Maria C
Nevot, María
Anta, Lourdes
Blanco, José L
Pérez-Elías, M Jesús
de Mendoza, Carmen
Martínez, Miguel A
Martinez-Picado, Javier
Menéndez-Arias, Luis
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy
author_facet Betancor, Gilberto
Garriga, César
Puertas, Maria C
Nevot, María
Anta, Lourdes
Blanco, José L
Pérez-Elías, M Jesús
de Mendoza, Carmen
Martínez, Miguel A
Martinez-Picado, Javier
Menéndez-Arias, Luis
author_sort Betancor, Gilberto
title Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy
title_short Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy
title_full Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy
title_fullStr Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy
title_full_unstemmed Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy
title_sort clinical, virological and biochemical evidence supporting the association of hiv-1 reverse transcriptase polymorphism r284k and thymidine analogue resistance mutations m41l, l210w and t215y in patients failing tenofovir/emtricitabine therapy
description
publisher BioMed Central
publishDate 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468358/
_version_ 1611915104236863488

Similar Items